Business

• Business
• PR Newswire

SINA Investors Have Opportunity to Lead Sina Corporation Securities Fraud Lawsuit

rvrisingnetwork October 18, 2025 0

NEW YORK, Oct. 17, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm,...

Read More Read more about SINA Investors Have Opportunity to Lead Sina Corporation Securities Fraud Lawsuit

• Business
• PR Newswire

Monport Treats Creators to Spooktacular Halloween Deals on Laser Engraving Machines

rvrisingnetwork October 18, 2025 0

NEW YORK, Oct. 17, 2025 /PRNewswire/ — As the Halloween season approaches, creators and small manufacturers are...

Read More Read more about Monport Treats Creators to Spooktacular Halloween Deals on Laser Engraving Machines

• Business
• PR Newswire

Tomorrowland 2025: Overcoming Adversity with Unity

rvrisingnetwork October 18, 2025 0

In 2025, that spirit was truly tested. Just days before opening, an unexpected fire severely damaged the...

Read More Read more about Tomorrowland 2025: Overcoming Adversity with Unity

• Business
• PR Newswire

Duchenne Muscular Dystrophy Therapeutics Market Surges Toward $6.6B by 2033 as Gene and RNA Therapies Redefine Treatment Paradigm

rvrisingnetwork October 18, 2025 0

AUSTIN, Texas and TOKYO, Oct. 17, 2025 /PRNewswire/ — The GlobalDuchenne Muscular Dystrophy (DMD) Therapeutics Market Size was...

Read More Read more about Duchenne Muscular Dystrophy Therapeutics Market Surges Toward $6.6B by 2033 as Gene and RNA Therapies Redefine Treatment Paradigm

• Business
• PR Newswire

Kelun-Biotech’s Core product Trastuzumab Botidotin Approved for Marketing by NMPA for HER2-positive BC

rvrisingnetwork October 18, 2025 0

CHENGDU, China, Oct. 17, 2025 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company”) announced that the Company’s human epidermal growth factor...

Read More Read more about Kelun-Biotech’s Core product Trastuzumab Botidotin Approved for Marketing by NMPA for HER2-positive BC

• Business
• PR Newswire

Laminated Glass Market worth $54.50 billion by 2030

rvrisingnetwork October 18, 2025 0

DELRAY BEACH, Fla., Oct. 17, 2025 /PRNewswire/ — The report ‘Laminated Glass Market by Glass Type (Heat-strengthened,...

Read More Read more about Laminated Glass Market worth $54.50 billion by 2030

• Business
• PR Newswire

SCG announces presentation of clinical results of SCG142 in patients with HPV-related carcinoma at ESMO 2025

rvrisingnetwork October 18, 2025 0

SINGAPORE, Oct. 18, 2025 /PRNewswire/ — SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing...

Read More Read more about SCG announces presentation of clinical results of SCG142 in patients with HPV-related carcinoma at ESMO 2025

• Business
• PR Newswire

New Coaching Program by Transformation Unlimited Guides Ambitious Millennial Professionals from Chaos to Clarity

rvrisingnetwork October 18, 2025 0

JUPITER ISLAND, Fla., Oct. 17, 2025 /PRNewswire/ — Burnout, mental clutter, and life chaos have become defining...

Read More Read more about New Coaching Program by Transformation Unlimited Guides Ambitious Millennial Professionals from Chaos to Clarity

• Business
• PR Newswire

GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings

rvrisingnetwork October 18, 2025 0

PATHFINDER 2 evaluated the safety and performance of the Galleri® multi-cancer early detection (MCED) test when used alongside...

Read More Read more about GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings

• Business
• PR Newswire

Nuvalent Presents Preliminary Data for Neladalkib in Advanced ALK-positive Solid Tumors Beyond NSCLC at ESMO 2025

rvrisingnetwork October 18, 2025 0

Encouraging preliminary activity observed across diverse set of advanced ALK-positive solid tumors Global enrollment ongoing for adult...

Read More Read more about Nuvalent Presents Preliminary Data for Neladalkib in Advanced ALK-positive Solid Tumors Beyond NSCLC at ESMO 2025